Pasithea Therapeutics Corp. (KTTA) EBIT Margin (2022)
Pasithea Therapeutics' EBIT Margin was -1679.52% in Q4 2022, up 84.24 percentage points from the prior quarter.
Powered by 
Analysis
Pasithea Therapeutics Corp. (KTTA) EBIT Margin (2022) Analysis & Trends
For FY2022, EBIT Margin at Pasithea Therapeutics came in at -2587.35%, up 27338.38 percentage points from FY2021.
- In earlier years, EBIT Margin was -29925.73% in FY2021.
- Per Business Quant data, KTTA's EBIT Margin in the three quarters before Q4 2022 was -1763.76% (Q3 2022), -19229.50% (Q2 2022) and -17605.34% (Q1 2022).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -1,679.52% |
| Sep 30, 2022 | -1,763.76% |
| Jun 30, 2022 | -19,229.50% |
| Mar 31, 2022 | -17,605.34% |
API Access
Pasithea Therapeutics Corp. EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=KTTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "KTTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=KTTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();